Idea Evolver
Idea Evolver specializes in ACNU technology, Digital Rx-to-OTC switches, and SEM solutions, providing regulatory services and technology for FDA compliance and enhanced market accessibility.
Specialties in ACNU Technology and Digital Rx-to-OTC Switches
Idea Evolver specializes in ACNU (Additional Conditions of Non-Prescription Use) technology, digital Rx-to-OTC switches, and SEM (Search Engine Marketing) solutions. The company's ACNU technology and digital platforms facilitate the transition of prescription medications to over-the-counter status, enhancing the accessibility of medications to consumers.
Regulatory Services for FDA Compliance
Idea Evolver provides regulatory services focused on FDA compliance and risk management. These services help ensure that products meet FDA standards and regulations. The company assists clients in navigating complex regulatory landscapes to bring medications from prescription-only to over-the-counter status, following rigorous FDA guidelines.
Technology-Assisted Self-Selection Web App
Idea Evolver offers a technology-assisted self-selection web app designed to aid in the transition of prescription medications to over-the-counter status. This innovative application leverages digital platforms and user-friendly interfaces to help consumers make informed choices about their medications, aligning with regulatory requirements and health standards.
RWE Forecasting and AI/ML Modeling
Idea Evolver utilizes Real-World Evidence (RWE) forecasting for market predictions and applies Artificial Intelligence/Machine Learning (AI/ML) modeling to gain a competitive advantage. These advanced analytical tools help the company anticipate market trends, optimize product development, and enhance decision-making processes.
Digital Rx-to-OTC Platform: CodeScripts
The digital Rx-to-OTC platform, named CodeScripts, is a key offering from Idea Evolver. CodeScripts is designed to increase the accessibility of medications by facilitating the transition from prescription to over-the-counter status. By using this platform, the company supports increased consumer access to essential medications while adhering to regulatory standards.
ACNU Pathway Participation
Idea Evolver is actively participating in the ACNU pathway, adhering to the FDA's proposed rule from June 2022 aimed at expanding the availability of nonprescription drugs. This involvement underscores the company's commitment to advancing public health and improving medication accessibility through regulatory innovation.
Office Locations
Idea Evolver operates from two main locations: 1315 Walnut Street, Suite 932, Philadelphia, Pennsylvania, 19107, and an office in Brooklyn. These strategic locations enable the company to serve a diverse client base and maintain its presence in key urban markets.